NephrologyOnline.net

Nephrology Xagena

XagenaNewsletter
Medical Meeting
Xagena Mappa
Mediexplorer.it

Search results for "Sutent"

Patients with metastatic renal cell carcinoma ( mRCC ) received Sunitinib ( Sutent ) in a global expanded-access program ( EAP ). Researchers have reported the efficacy and safety results for the ...


Top-line results from the CABOSUN randomized phase 2 trial of Cabozantinib ( Cabometyx; Cometriq ) in patients with previously untreated advanced renal cell carcinoma ( RCC ) were announced. The tria ...


A combination of the immune checkpoint blocker, Avelumab ( Bavencio ), plus the tyrosine kinase inhibitor ( TKI ), Axitinib ( Inlyta ), significantly improves progression-free survival ( PFS ) in pre ...


Cabozantinib ( Cabometyx ) is an oral multitargeted tyrosine kinase inhibitor ( TKI ) that potently inhibits MET and AXL, both associated with poor prognosis in renal cell carcinoma ( RCC ), next to v ...